Osteoporosis Treatment Market Size, Share and Global Trend By Therapy Type (Bisphosphonates, Hormonal Therapy, Monoclonal Antibodies Medications, Selective Estrogen Inhibitors Modulators (SERM), Bone-Building Medications, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026.
Changing lifestyle and rising geriatric population are identified as chief drivers of the global osteoporosis treatment market. Fortune Business Insights in a report, titled “Osteoporosis Treatment Market Size, Share and Global Trend By Therapy Type (Bisphosphonates, Hormonal Therapy, Monoclonal Antibodies Medications, Selective Estrogen Inhibitors Modulators (SERM), Bone-Building Medications, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Geography Forecast till 2026,” offers key insights into the global market.
It analyzes the factors enabling growth in the market and threats restraining its trajectory. The report also covers some of the leading segments in the osteoporosis treatment market. It also studies in detail the impact of latest innovations in the market. Policies encouraging and restricting growth are studied in detail as well. To offer an executive-level blueprint, the report compiles information obtained from trusted resources in a comprehensive chapter-wise format. A section is exclusively dedicated to studying the competitive landscape of the market. The report therefore profiles some of the leading market players and studies in detail growth strategies adopted by them.
Rising Incidence of Osteoporosis to Fuel Demand for Effective Treatment
The incidence of osteoporosis is high among women, especially after menopause. Besides this having low body weight or sex hormones can be common causes of the disease. In addition, rising prevalence of smoking and poor diet bolsters the risk of osteoporosis. As per the International Osteoporosis Foundation, osteoporosis causes nearly 8.9 fractures worldwide in a year. The demand for osteoporosis treatment is expected to get stoked in response to the rising burden of the disease. Furthermore, the surge in research and development activities around the world is expected to boost the market in the coming years. “An increasing number of pharmaceutical organizations are investing on research and development on minimally invasive therapies. Besides this the focus on novel therapeutics has continued to increase,” said a lead analyst at Fortune Business Insights. “These factors definitely stoke the demand for osteoporosis treatment and will continue to do so through the course of the forecast period,” he added.
Looming Patent Expiries Pose Threat
Despite the aforementioned growth opportunities, the market is facing challenges on account of the impending patent expiry of a few blockbuster drugs. Furthermore, competition is expected to rise for mainstream market players following the launch of generics. Nonetheless, FDA approvals will give significant impetus to the market in the coming years. Recently in April 2019, UCB and Amgen Inc., announced receiving FDA approval on EVENITY to offer treatment for post-menopausal women who are at a high risk of fracture.
North America Emerges as Lucrative Market for Osteoporosis Treatment
To offer a comprehensive overview, the report segments the global osteoporosis treatment market in terms of region into North America, the Middle East and Africa, Latin America, Europe, and Asia Pacific. Of these, North America is expected to show high demand. According to the National Osteoporosis Foundation, nearly 10 million Americans suffer from osteoporosis. The number is forecast to rise considerably in the coming years, which explains the high demand for osteoporosis treatment in the region.
Some of the leading players operating in the osteoporosis treatment market are:
- Hoffmann-La Roche Ltd
Eli Lilly and Company
Merck & Co., Inc.
Novartis AG, Pfizer Inc
DAIICHI SANKYO COMPANY, LIMITED
Novo Nordisk A/S
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]